Hydrochloric Acid → HCID 25066064, compound
Reaction equation
Cl.[CH2:2]1[C:7]2([CH2:12][CH2:11][CH:10]([CH2:13][C:14]([O:16][CH3:17])=[O:15])[CH2:9][CH2:8]2)[CH2:6][CH2:5][NH:4][CH2:3]1.CCN(C(C)C)C(C)C.Cl[C:28]([O:30][CH:31]1[CH:38]2[CH2:39][CH:34]3[CH2:35][CH:36]([CH2:40][CH:32]1[CH2:33]3)[CH2:37]2)=[O:29].Cl>C(Cl)Cl>[CH3:17][O:16][C:14](=[O:15])[CH2:13][CH:10]1[CH2:11][CH2:12][C:7]2([CH2:2][CH2:3][N:4]([C:28]([O:30][CH:31]3[CH:32]4[CH2:40][CH:36]5[CH2:35][CH:34]([CH2:39][CH:38]3[CH2:37]5)[CH2:33]4)=[O:29])[CH2:5][CH2:6]2)[CH2:8][CH2:9]1Participants
Procedure
A vial was charged with methyl 2-(3-azaspiro[5.5]undecan-9-yl)acetate HCl salt (31 mg, 0.12 mmol) and DIEA (45 μL, 0.25 mmol). A solution of 2-adamantyl chloroformate (25 mg, 0.12 mmol) in CH2Cl2 (2 mL) was added and the mixture was stirred overnight at rt. A 10-mL Chem-Elut cartridge was wetted with 5% aq HCl (6 mL) and allowed to stand for 5 min. The reaction mixture was applied to the cartridge and eluted with ether (20 mL). The eluate was evaporated to dryness and the residue was purified by preparative HPLC to afford (2-adamantyl) 9-(2-methoxy-2-oxoethyl)-3-azaspiro[5.5]undecane-3-carboxylate (35 mg, 74%). LC-MS Method 1 tR=2.52 min, m/z=404; 1H NMR (CDCl3) δ=1.05-2.10 (27H), 2.23 (d, 2H), 3.41 (m, 4H), 3.69 (s, 3H), 4.82 (s, 1H).
Workup
- waitto stand for 5 min
- washeluted with ether (20 mL)
- customThe eluate was evaporated to dryness
- customthe residue was purified by preparative HPLC
Sources & evidence
- ORD record
- ord-b6f9c51b0852480497652a23bcc80c7f
- Source dataset
- uspto-grants-2015_01
- Patent number
- US08927715B2
Reaction notes
Loading…